885 related articles for article (PubMed ID: 27535979)
1. PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course.
Nishino M; Ramaiya NH; Awad MM; Sholl LM; Maattala JA; Taibi M; Hatabu H; Ott PA; Armand PF; Hodi FS
Clin Cancer Res; 2016 Dec; 22(24):6051-6060. PubMed ID: 27535979
[TBL] [Abstract][Full Text] [Related]
2. Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
Nishino M; Chambers ES; Chong CR; Ramaiya NH; Gray SW; Marcoux JP; Hatabu H; Jänne PA; Hodi FS; Awad MM
Cancer Immunol Res; 2016 Apr; 4(4):289-93. PubMed ID: 26865455
[TBL] [Abstract][Full Text] [Related]
3. Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy in patients with neuroendocrine tumors: a radiographic pattern-based approach.
Nishino M; Brais LK; Brooks NV; Hatabu H; Kulke MH; Ramaiya NH
Eur J Cancer; 2016 Jan; 53():163-70. PubMed ID: 26760924
[TBL] [Abstract][Full Text] [Related]
4. Drug-Related Pneumonitis During Mammalian Target of Rapamycin Inhibitor Therapy: Radiographic Pattern-Based Approach in Waldenström Macroglobulinemia as a Paradigm.
Nishino M; Boswell EN; Hatabu H; Ghobrial IM; Ramaiya NH
Oncologist; 2015 Sep; 20(9):1077-83. PubMed ID: 26205737
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.
Nishino M; Giobbie-Hurder A; Hatabu H; Ramaiya NH; Hodi FS
JAMA Oncol; 2016 Dec; 2(12):1607-1616. PubMed ID: 27540850
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase inhibitor related pneumonitis in patients with non-small cell lung cancer: Clinical and radiologic characteristics and risk factors.
Hwang HJ; Kim MY; Choi CM; Lee JC
Medicine (Baltimore); 2019 Nov; 98(48):e18131. PubMed ID: 31770246
[TBL] [Abstract][Full Text] [Related]
7. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.
Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T
J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875
[TBL] [Abstract][Full Text] [Related]
8. High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review.
Koyama N; Iwase O; Nakashima E; Kishida K; Kondo T; Watanabe Y; Takahashi H; Umebayashi Y; Ogawa Y; Miura H
BMC Pulm Med; 2018 Jan; 18(1):23. PubMed ID: 29378571
[TBL] [Abstract][Full Text] [Related]
9. Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management.
Nishino M; Kusumoto M; Bankier AA; Kurihara Y; Zhang L; Rasheed Z; Meinhardt G; Arunachalam M; Taitt C; Wang Q; Powell CA
JCO Precis Oncol; 2023 Sep; 7():e2300391. PubMed ID: 38061008
[TBL] [Abstract][Full Text] [Related]
10. A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia.
Fujimoto D; Morimoto T; Ito J; Sato Y; Ito M; Teraoka S; Otsuka K; Nagata K; Nakagawa A; Tomii K
Lung Cancer; 2017 Sep; 111():1-5. PubMed ID: 28838377
[TBL] [Abstract][Full Text] [Related]
11. Radiographic patterns of symptomatic radiation pneumonitis in lung cancer patients: Imaging predictors for clinical severity and outcome.
Thomas R; Chen YH; Hatabu H; Mak RH; Nishino M
Lung Cancer; 2020 Jul; 145():132-139. PubMed ID: 32447116
[TBL] [Abstract][Full Text] [Related]
12. [Immune-related pneumonitis caused by programmed death-1 inhibitor Pembrolizumab: a case report and literature review].
Chen YL; Zhao J; Jia R; Wang HY; Zheng J; Bai CQ; Wang MZ; Xu JM
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Oct; 40(10):736-743. PubMed ID: 29050127
[No Abstract] [Full Text] [Related]
13. Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.
Naidoo J; Wang X; Woo KM; Iyriboz T; Halpenny D; Cunningham J; Chaft JE; Segal NH; Callahan MK; Lesokhin AM; Rosenberg J; Voss MH; Rudin CM; Rizvi H; Hou X; Rodriguez K; Albano M; Gordon RA; Leduc C; Rekhtman N; Harris B; Menzies AM; Guminski AD; Carlino MS; Kong BY; Wolchok JD; Postow MA; Long GV; Hellmann MD
J Clin Oncol; 2017 Mar; 35(7):709-717. PubMed ID: 27646942
[TBL] [Abstract][Full Text] [Related]
14. Risk of Pneumonitis with the Use of Different Immune Checkpoint Inhibitors in a Mexican Population.
Dávila-Dupont D; Motola-Kuba D; Dorantes-Heredia R; González-Alonso BK; Alcántara-Velarde T; García-Santisteban R; Martínez-Sámano JE; Grimaldo-Roque HJ; Ruiz-Morales JM
Oncology; 2019; 96(5):268-272. PubMed ID: 30861515
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.
Watanabe S; Ota T; Hayashi M; Ishikawa H; Otsubo A; Shoji S; Nozaki K; Ichikawa K; Kondo R; Miyabayashi T; Miura S; Tanaka H; Abe T; Okajima M; Terada M; Ishida T; Iwashima A; Sato K; Yoshizawa H; Kikuchi T
Cancer Med; 2020 May; 9(9):3070-3077. PubMed ID: 32150668
[TBL] [Abstract][Full Text] [Related]
16. Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis.
Yamaguchi T; Shimizu J; Hasegawa T; Horio Y; Inaba Y; Yatabe Y; Hida T
Lung Cancer; 2018 Nov; 125():212-217. PubMed ID: 30429022
[TBL] [Abstract][Full Text] [Related]
17. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Rizvi NA; Mazières J; Planchard D; Stinchcombe TE; Dy GK; Antonia SJ; Horn L; Lena H; Minenza E; Mennecier B; Otterson GA; Campos LT; Gandara DR; Levy BP; Nair SG; Zalcman G; Wolf J; Souquet PJ; Baldini E; Cappuzzo F; Chouaid C; Dowlati A; Sanborn R; Lopez-Chavez A; Grohe C; Huber RM; Harbison CT; Baudelet C; Lestini BJ; Ramalingam SS
Lancet Oncol; 2015 Mar; 16(3):257-65. PubMed ID: 25704439
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors.
Asher N; Marom EM; Ben-Betzalel G; Baruch EN; Steinberg-Silman Y; Schachter J; Shapira-Frommer R; Markel G
Oncologist; 2019 May; 24(5):640-647. PubMed ID: 30777894
[TBL] [Abstract][Full Text] [Related]
19. Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanoma.
Baba T; Sakai F; Kato T; Kusumoto M; Kenmotsu H; Sugiura H; Tominaga J; Oikado K; Sata M; Endo M; Yanagawa N; Sasaki S; Iwasawa T; Saito Y; Fujiwara Y; Ohe Y; Yamazaki N; Sakamoto T; Koshiba T; Kuwano K
Future Oncol; 2019 Jun; 15(16):1911-1920. PubMed ID: 31020849
[No Abstract] [Full Text] [Related]
20. Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody.
Shibaki R; Murakami S; Matsumoto Y; Yoshida T; Goto Y; Kanda S; Horinouchi H; Fujiwara Y; Yamamoto N; Kusumoto M; Yamamoto N; Ohe Y
Cancer Immunol Immunother; 2020 Jan; 69(1):15-22. PubMed ID: 31745589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
